4133.TW

Abnova (Taiwan) Corporation [4133.TW] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

4133.TW Stock Summary

Top 10 Correlated ETFs

4133.TW

Top 10 Correlated Stocks

4133.TW

In the News

4133.TW Financial details

Company Rating
-
Market Cap
1.91B
Income
43.68M
Revenue
382.05M
Book val./share
-
Cash/share
-
Dividend
0.8
Dividend %
2.23%
Employees
110
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
47.88
Forward P/E
-
PEG
-11.64
P/S
5.48
P/B
1.67
P/C
-
P/FCF
31.85
Quick Ratio
6.67
Current Ratio
12.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.73
EPS next Y
-
EPS next Q
-
EPS this Y
-41.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
67.94%
Revenue last 5Y
-1.6%
Revenue Q/Q
0.08%
EPS Q/Q
5.88%
-
-
-
-
SMA20
-7.05%
SMA50
-9.26%
SMA100
-5.15%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.04%
Gross Margin
46%
Oper. Margin
15%
Profit Margin
11%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
30.95-38.85
52W High
-24.47%
52W Low
-4.33%
RSI
60.88
Rel Volume
1.46
Avg Volume
199.55K
Volume
291.31K
Perf Week
9.75%
Perf Month
-4.17%
Perf Quarter
-1.88%
Perf Half Y
-2.88%
-
-
-
-
Beta
0.413
-
-
Volatility
0.76%, 2.38%
Prev Close
0%
Price
28.7
Change
1.59%

4133.TW Financial Performance

4133.TW Dividend History

4133.TW Frequently Asked Questions

What is Abnova (Taiwan) Corporation stock symbol ?

Abnova (Taiwan) Corporation is a TW stock and trading under the symbol 4133.TW

What is Abnova (Taiwan) Corporation stock quote today ?

Abnova (Taiwan) Corporation stock price is $28.7 today.

Is Abnova (Taiwan) Corporation stock public?

Yes, Abnova (Taiwan) Corporation is a publicly traded company.

Something similar

Top by Market Cap
LLY.SW
BRK-B
JPM
CMC.DE
AMZ.DE
Top Correlated ETFs
ANRJ.L
6TVL.DE
EJAH.DE
ESIN.DE
EXI1.DE
Top Correlated Stocks
6456.TW
AHT.L
TCAP.L
3714.TW
OUT1V.HE
Similar Market Cap
600565.SS
NVST
BRBI11.SA
0RGI.L
NECCLTD.NS

Company Profile

Healthcare Biotechnology
  • Volume Average 199.55K
  • Market Capitalization 1.91B
  • Employee 110
  • CEO Yi Huang Huang
  • Headquarters Taipei,TW
  • IPO Date 2009-12-28
  • Website https://www.abnova.com

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.